Literature DB >> 9112586

Positron emission tomography studies of sleep and sleep disorders.

P Maquet1.   

Abstract

Using positron emission tomography (PET) it is possible to perform an in vivo study of cerebral physiological and biochemical processes in man. Employing this technique in sleep studies, decreased cerebral metabolic rates for glucose during slow wave sleep compared with those seen during wakefulness were first demonstrated, whereas similar rates of cerebral glucose metabolism were observed during paradoxical sleep and wakefulness. More recently, regional modifications of cerebral blood flow during sleep have also been demonstrated. During slow wave sleep, cerebral blood flow is decreased particularly in the prefrontal cortex. Rapid eye movement sleep is characterized by activation of the pons, thalami, amygdaloid complexes and a number of cortical areas (e.g. the anterior cingulate cortex). Although data remain incomplete, a variety of sleep disorders, including narcolepsy, fatal familial insomnia and continuous spike-and-wave discharges during slow sleep have been investigated. These results are briefly reviewed.

Entities:  

Mesh:

Year:  1997        PMID: 9112586     DOI: 10.1007/bf03160568

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  33 in total

1.  Human regional cerebral blood flow during rapid-eye-movement sleep.

Authors:  P L Madsen; S Holm; S Vorstrup; L Friberg; N A Lassen; G Wildschiødtz
Journal:  J Cereb Blood Flow Metab       Date:  1991-05       Impact factor: 6.200

2.  Functional neuroanatomy of human rapid-eye-movement sleep and dreaming.

Authors:  P Maquet; J Péters; J Aerts; G Delfiore; C Degueldre; A Luxen; G Franck
Journal:  Nature       Date:  1996-09-12       Impact factor: 49.962

3.  Cerebral and local cerebral metabolism in the cat during slow wave and REM sleep.

Authors:  P Ramm; B J Frost
Journal:  Brain Res       Date:  1986-02-12       Impact factor: 3.252

4.  Regional cerebral blood-flow measured by HMPAO and SPECT in a 5-year-old boy with Landau-Kleffner syndrome.

Authors:  S E Mouridsen; C Videbaek; H Søgaard; A R Andersen
Journal:  Neuropediatrics       Date:  1993-02       Impact factor: 1.947

5.  Treatment of restless legs syndrome with levodopa plus benserazide.

Authors:  S Akpinar
Journal:  Arch Neurol       Date:  1982-11

6.  Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: a double-blind, controlled study.

Authors:  C Brodeur; J Montplaisir; R Godbout; R Marinier
Journal:  Neurology       Date:  1988-12       Impact factor: 9.910

7.  Landau-Kleffner syndrome: a pharmacologic study of five cases.

Authors:  C Marescaux; E Hirsch; S Finck; P Maquet; E Schlumberger; F Sellal; M N Metz-Lutz; Y Alembik; E Salmon; G Franck
Journal:  Epilepsia       Date:  1990 Nov-Dec       Impact factor: 5.864

8.  Cerebral O2 metabolism and cerebral blood flow in humans during deep and rapid-eye-movement sleep.

Authors:  P L Madsen; J F Schmidt; G Wildschiødtz; L Friberg; S Holm; S Vorstrup; N A Lassen
Journal:  J Appl Physiol (1985)       Date:  1991-06

9.  Positron emission tomography study of human narcolepsy: no increase in striatal dopamine D2 receptors.

Authors:  J O Rinne; C Hublin; M Partinen; H Ruottinen; U Ruotsalainen; K Någren; P Lehikoinen; A Laihinen
Journal:  Neurology       Date:  1995-09       Impact factor: 9.910

10.  Focal cerebral metabolic abnormality in a patient with continuous spike waves during slow-wave sleep.

Authors:  Y D Park; J M Hoffman; R A Radtke; G R DeLong
Journal:  J Child Neurol       Date:  1994-04       Impact factor: 1.987

View more
  10 in total

1.  Neural connections of the posteromedial cortex in the macaque.

Authors:  Josef Parvizi; Gary W Van Hoesen; Joseph Buckwalter; Antonio Damasio
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

2.  Sleep and Glucose Intolerance/Diabetes Mellitus.

Authors:  Mary Ip; Babak Mokhlesi
Journal:  Sleep Med Clin       Date:  2007

3.  Identifying the default-mode component in spatial IC analyses of patients with disorders of consciousness.

Authors:  Andrea Soddu; Audrey Vanhaudenhuyse; Mohamed Ali Bahri; Marie-Aurelie Bruno; Mélanie Boly; Athena Demertzi; Jean-Flory Tshibanda; Christophe Phillips; Mario Stanziano; Smadar Ovadia-Caro; Yuval Nir; Pierre Maquet; Michele Papa; Rafael Malach; Steven Laureys; Quentin Noirhomme
Journal:  Hum Brain Mapp       Date:  2011-04-11       Impact factor: 5.038

Review 4.  Insomnia in patients with depression: some pathophysiological and treatment considerations.

Authors:  Ripu D Jindal
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 5.  Neuroimaging of sleep and sleep disorders.

Authors:  Eric A Nofzinger
Journal:  Curr Neurol Neurosci Rep       Date:  2006-03       Impact factor: 5.081

6.  Genes involved in the astrocyte-neuron lactate shuttle (ANLS) are specifically regulated in cortical astrocytes following sleep deprivation in mice.

Authors:  Jean-Marie Petit; Joël Gyger; Sophie Burlet-Godinot; Hubert Fiumelli; Jean-Luc Martin; Pierre J Magistretti
Journal:  Sleep       Date:  2013-10-01       Impact factor: 5.849

Review 7.  Interacting epidemics? Sleep curtailment, insulin resistance, and obesity.

Authors:  Eliane A Lucassen; Kristina I Rother; Giovanni Cizza
Journal:  Ann N Y Acad Sci       Date:  2012-07-24       Impact factor: 5.691

8.  What Physiological Changes and Cerebral Traces Tell Us about Adhesion to Fiction During Theater-Watching?

Authors:  Marie-Noëlle Metz-Lutz; Yannick Bressan; Nathalie Heider; Hélène Otzenberger
Journal:  Front Hum Neurosci       Date:  2010-08-19       Impact factor: 3.169

Review 9.  Are Absence Epilepsy and Nocturnal Frontal Lobe Epilepsy System Epilepsies of the Sleep/Wake System?

Authors:  Péter Halász
Journal:  Behav Neurol       Date:  2015-06-14       Impact factor: 3.342

Review 10.  The functional significance of delta oscillations in cognitive processing.

Authors:  Thalía Harmony
Journal:  Front Integr Neurosci       Date:  2013-12-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.